Respiratory therapeutic electric heat source face mask

Abstract

A therapeutic face mask apparatus for wearers with resistant respiratory viruses, is connected to a heat gun that provides adjustable heated and humidified air for inhalation. The heat gun heats ambient air that is breathed in through the face mask during normal breathing, which is worn over the nose and mouth of a person. A temperature gauge monitors temperature for future adjustment of the amount of heat generating current to raise the heat to a predetermined temperature to deactivate resistant viruses in compromised upper and/or lower respiratory systems of the wearer. The air in the chamber is heated for inhalation by a resistive element in the heat gun. The temperature of the resistive material (and by extension the warm air generated), is regulated/adjusted by increasing or decreasing the current output settings on the power source, so that heated and pressured air is produced.

What is claimed is: 
     
         1 . A therapeutic face mask apparatus for a patient afflicted with the virus causing COVID-19 disease, (SARS-CoV-2) comprising:
 a heat source that provides adjustable heated and pressurized air for inhalation, said heated and pressurized air being unadulterated ambient atmospheric air;   a flexible conduit for delivering said heated and pressurized air from said heat source to said mask;   said face mask adapted to being worn over and covering the nose and mouth of the patient;   said heat source delivering to said face mask said heated and pressurized air at a predetermined temperature in a range of from about 130 deg. F. to about 175 deg. F., but not exceeding a predetermined safety limit and at a pressure not exceeding a predetermined safety limit; and   said heat source containing a safety interlock to monitor the temperature and the pressure of said heated and pressurized air delivered to said patient and to shut down said heat source if said temperature or said pressure of said air delivered to said patient exceeds said preselected safety limits.   
     
     
         2 . The therapeutic face mask apparatus as in  claim 1  wherein said heat source is a heat gun having temperature and air pressure controls capable of maintaining said heated air below said predetermined safety limits for temperature and pressure. 
     
     
         3 . The therapeutic face mask apparatus as in  claim 1  wherein said heat source includes a switch wherein if one of said predetermined safety limits is exceeded, the heat gun will not operate and a visual display with display indicates an “OFF” mode. 
     
     
         4 . The therapeutic face mask apparatus as in  claim 1  in which said interlock includes a mechanism for locking in a preferred predetermined temperature and pressure range capable of inactivating the virus causing COVID-19 disease (SARS-CoV-2). 
     
     
         5 . The therapeutic face mask apparatus as in  claim 1  in which the preselected upper temperature safety limit is 200 deg. F. and the preselected upper air pressure safety limit is 5.4 psi. 
     
     
         6 . The therapeutic face mask apparatus as in  claim 2  wherein said heat gun includes a keyboard capable of programing said preferred predetermined temperatures and air pressures. 
     
     
         7 . The face mask of  claim 6  in which said power source is AC power transformed to a low voltage DC power source. 
     
     
         8 . The face mask of  claim 6  in which said power source is a low voltage power source. 
     
     
         9 . The face mask of  claim 1  having a thermometer extending into said face mask for visually maintaining air temperature within said face mask. 
     
     
         10 . A method of destroying a virus causing COVID-19 disease, (SARS-CoV-2) within the respiratory system of a patient, comprising the steps of:
 placing a mask on the face of said patient covering the nose and mouth of said patient;   connecting a heated air source to deliver unadulterated ambient atmospheric air through a hose to said mask;   heating said air in said air source to a predetermined temperature exceeding activation temperature of the virus causing COVID-19 disease, (SARS-CoV-2) to destroy the virus in the person's respiratory system, said predetermined temperature being preferably in a range of from about 130 deg. F. to about 175 deg. F., but not exceeding a predetermined safety limit;   supplying said heated air at a pressure not exceeding a preselected safety limit; and   providing said air source with a safety interlock to monitor the temperature and the pressure of said heated and pressurized air delivered to said patient and to shut down said heat source if said temperature or said pressure of said air delivered to said patient exceeds one of said preselected safety limits.   
     
     
         11 . The method of  claim 10  wherein said air source is a heat gun having temperature and air pressure controls for maintaining said heated air below a predetermined upper limit threshold of temperature and air pressure for safe inhalation. 
     
     
         12 . The method of  claim 11  wherein said heat gun includes a switch wherein if one of said preselected limits is exceeded, the heat gun will not operate and a visual display with display indicates an “OFF” mode. 
     
     
         13 . The method of  claim 10  further providing a mechanism for locking in a predetermined temperature and pressure range. 
     
     
         14 . The method of  claim 10  wherein said preselected pressure upper safety limit is 5.4 psi. 
     
     
         15 . The method of  claim 13  wherein said heat gun includes a keyboard capable of programing said first and second predetermined temperatures and air pressures. 
     
     
         16 . The method of  claim 10  in which said power source is AC power transformed to a low voltage DC power source. 
     
     
         17 . The method of  claim 10  in which said power source is a low voltage power source. 
     
     
         18 . The method of  claim 10  in which said power source is a battery. 
     
     
         19 . The method of  claim 10  in which said power source is AC power. 
     
     
         20 . The method of  claim 10  comprising the step of visually maintaining air temperature within said face mask by using a thermometer extending into said face mask. 
     
     
         21 . A method of treating selected pathogens and lung diseases, selected from the group consisting of bacteria, viruses, fungi,  mycoplasma , asthma, mesothelioma, lung cancer, dysplasia, chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, pulmonary fibrosis, cystic fibrosis, pneumonia, heart disease and breast, prostate, pancreatic, skin, non-Hodgkin lymphoma, kidney, thyroid, brain, endometrial leukemia, sarcoma, colorectal, gastrointestinal and lymphoma cancers, which metastasize from other sites to the lung, comprising the steps of:
 placing a mask on the face of a person, said mask covering the nose and mouth of the person;   connecting a heated air source to deliver pure, ambient, atmospheric undiluted air through a hose to said mask; said heat source containing a safety interlock to monitor the temperature and the pressure of said heated and pressurized air delivered to said patient and to shut down said heat source if said temperature or said pressure of said air delivered to said patient exceeds said preselected safety limits; and,   heating said air to a temperature exceeding activation temperature of the pathogen to destroy the selected pathogen,   to inactivate said pathogens and to treat said lung diseases.   
     
     
         22 . A method of augmenting cytotoxic chemotherapy, radiation or immunotherapy for cancers of the lung, upper and lower respiratory tract, and cancers of body parts of a person by supplying heated air to the person afflicted with said cancers of the lung, upper and lower respiratory tract, and cancers of body parts of a person, comprising the steps of:
 placing a CPAP mask on the face of said person, said mask comprising a housing mask covering said nose and mouth of said person;   connecting a heated air source to deliver pure, ambient, atmospheric undiluted air through a hose to said CPAP mask, said heat source containing a safety interlock to monitor the temperature and the pressure of said heated and pressurized air delivered to said patient and to shut down said heat source if said temperature or said pressure of said air delivered to said patient exceeds said preselected safety limits;   heating said air to a temperature exceeding activation temperature of a pathogen, to destroy the selected pathogen in person's respiratory system; and   wherein said heated air causes an immunological upregulation of immune stimulatory molecules, such as heat shock proteins, at the sites of the person being treated with said immunotherapy.